ICD10 code of Crigler-Najjar syndrome and ICD9 code

Crigler-Najjar syndrome is classified under ICD-10 code E80.5 (hereditary disorders of bilirubin metabolism) and was previously categorized under ICD-9 code 277.4. These diagnostic codes are essential for medical documentation, insurance billing, and clinical tracking for patients living with this rare liver disorder.

What is Crigler-Najjar syndrome and how is it classified?

Crigler-Najjar syndrome is a rare, autosomal recessive metabolic disorder characterized by the inability of the liver to properly process bilirubin, a yellow pigment produced by the breakdown of red blood cells. Because the enzyme bilirubin-UGT is either severely deficient (Type I) or significantly reduced (Type II), patients experience persistent, severe jaundice. Accurate coding is vital for the 35 community members on DiseaseMaps.org and others worldwide to ensure they receive appropriate diagnostic support and specialized care. While the ICD-10 code E80.5 encompasses broader bilirubin metabolism disorders, it remains the standard identifier for Crigler-Najjar syndrome in clinical settings.

What are the differences between Type I and Type II?

Clinicians distinguish between two primary forms of Crigler-Najjar syndrome based on the severity of the enzyme deficiency and the response to treatment. Understanding these types is crucial for prognosis and therapeutic planning:

• Type I: Characterized by a complete absence of UGT1A1 enzyme activity. This leads to extremely high levels of unconjugated bilirubin, posing a high risk for kernicterus (bilirubin-induced brain damage) if not managed aggressively with phototherapy or liver transplantation.


• Type II (also known as Arias syndrome): Involves a partial deficiency of the enzyme (usually less than 10% of normal activity). Patients with this form of Crigler-Najjar syndrome often show a significant reduction in bilirubin levels when treated with phenobarbital, which induces the remaining enzyme activity.

How is the diagnosis of Crigler-Najjar syndrome confirmed?

The diagnosis of Crigler-Najjar syndrome is typically suspected in infants presenting with unconjugated hyperbilirubinemia in the absence of hemolysis or liver disease. To confirm the diagnosis, physicians perform a combination of clinical assessments and specialized testing:

1. Measurement of serum bilirubin levels, which are typically elevated (often above 20 mg/dL in Type I).


2. Molecular genetic testing to identify mutations in the UGT1A1 gene, which is the gold standard for confirming Crigler-Najjar syndrome.


3. Liver biopsy for enzymatic analysis to determine the specific level of UGT activity, though this is performed less frequently now that genetic testing is widely available.

Why is early identification of Crigler-Najjar syndrome critical?

Because Crigler-Najjar syndrome can lead to life-altering neurological complications, early intervention is paramount. The psychosocial impact of living with a chronic, visible condition like Crigler-Najjar syndrome can be significant for patients and their families. Many patients find that connecting with a community, such as the 35 individuals already sharing their experiences on DiseaseMaps.org, helps mitigate the isolation often felt when managing such a rare diagnosis. By utilizing the correct ICD codes, families ensure that their medical records accurately reflect the specific nature of this condition, facilitating access to necessary resources and specialized pediatric hepatology care.

Next steps

• Consult with a pediatric hepatologist or a metabolic specialist to review your current management plan.


• Ensure your medical records and insurance claims correctly utilize the ICD-10 code E80.5.


• Join the DiseaseMaps.org community to connect with other families navigating the daily realities of this condition.


• Discuss the latest advancements in gene therapy clinical trials with your medical team.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice; always consult with a qualified healthcare professional regarding your specific health condition.

References

• Orphanet: Crigler-Najjar syndrome (ORPHA:205).


• NIH Genetic and Rare Diseases (GARD) Information Center: Crigler-Najjar syndrome.


• OMIM (Online Mendelian Inheritance in Man): Crigler-Najjar syndrome Type I (#218800).


• World Health Organization: International Classification of Diseases, 10th Revision (ICD-10).